Search clinical trials for: rilzabrutinib SAR444671
Total 25 results
-
SanofiActive, not recruitingWarm Autoimmune Hemolytic Anemia (wAIHA)United States, Austria, China, Denmark, Germany, Hungary, Italy, Spain, United Kingdom
-
Principia Biopharma, a Sanofi CompanyCompletedHealthy VolunteersAustralia
-
SanofiRecruitingHealthy Volunteers | Autoimmune DisorderUnited States
-
SanofiCompletedAtopic DermatitisNetherlands, Chile, United States, Canada, Czechia, Germany, Poland
-
SanofiCompletedAsthmaSpain, Korea, Republic of, Chile, Mexico, United Kingdom, Argentina, Bulgaria, Canada, Hungary, Poland, Romania, Turkey, Germany
-
SanofiActive, not recruitingChronic Spontaneous UrticariaChile, Taiwan, Argentina, Germany, Canada, Russian Federation, Netherlands, Korea, Republic of, Spain, Greece, Italy, Japan, Poland
-
Principia Biopharma, a Sanofi CompanyMassachusetts General HospitalActive, not recruitingImmunoglobulin G4 Related DiseaseUnited States, Canada, France, Italy, Spain
-
Principia Biopharma, a Sanofi CompanyActive, not recruitingImmune Thrombocytopenia | Immune Thrombocytopenic PurpuraUnited States, Australia, Bulgaria, Canada, Czechia, Netherlands, Norway, United Kingdom
-
Principia Biopharma, a Sanofi CompanyPrincipia Biopharma Australia Pty Ltd.CompletedPemphigus VulgarisIsrael, Australia, Greece, Croatia, France
-
Principia Biopharma, a Sanofi CompanyRecruitingImmune ThrombocytopeniaUnited States, China, Argentina, Australia, Brazil, Canada, France, Hungary, Israel, Korea, Republic of, Mexico, Russian Federation, Singapore, Spain, Thailand, United Kingdom, Austria, Chile, Germany, Italy, Japan, Netherlands, Norway and more
-
Genzyme, a Sanofi CompanyCompletedFabry DiseaseFrance, Poland, United States, Russian Federation, United Kingdom
-
Genzyme, a Sanofi CompanyCompletedHealthy Volunteers | Polycystic Kidney, Autosomal DominantUnited States
-
Genzyme, a Sanofi CompanyCompletedFabry DiseaseFrance, Poland, United States, Russian Federation, United Kingdom
-
SanofiKymera Therapeutics, Inc.RecruitingPhase 2 Study of SAR444656 in Adult Participants With Moderate to Severe Atopic Dermatitis (ADVANTA)Atopic DermatitisGreece, Poland, United States, Germany
-
SanofiKymera Therapeutics, Inc.RecruitingHidradenitis SuppurativaSpain, United States, Germany, Greece, Poland
-
Genzyme, a Sanofi CompanyTerminatedParkinson's DiseaseUnited States, Austria, Canada, France, Germany, Greece, Israel, Italy, Japan, Norway, Portugal, Singapore, Spain, Sweden, Taiwan, United Kingdom
-
Principia Biopharma, a Sanofi CompanyTerminatedPemphigusUnited States, Argentina, Australia, Brazil, Bulgaria, Canada, Croatia, France, Germany, Greece, Israel, Italy, Poland, Serbia, Spain, Taiwan, Turkey, Ukraine, United Kingdom
-
Kadmon, a Sanofi CompanyRecruitingChronic Graft Versus Host DiseaseUnited States
-
Kadmon, a Sanofi CompanyCompletedImmune System Disorder (Healthy Volunteer)United States
-
Kadmon, a Sanofi CompanyCompletedImmune System Disorder (Healthy Volunteer)United States
-
Kadmon, a Sanofi CompanyCompletedImmune System Disorder (Healthy Volunteer)United States
-
Kadmon, a Sanofi CompanyCompletedImmune System Disorder (Healthy Volunteers)United States
-
SanofiRecruitingCancer | NeoplasmUnited States, Israel
-
SanofiRecruitingChronic Graft Versus Host DiseaseAustralia, Spain, Sweden, Czechia, United Kingdom, United States, Italy, Germany, Canada, Israel, Belgium, Denmark
-
SanofiRecruitingPlasma Cell Myeloma RefractoryFrance, Australia, Greece, Italy, Norway, United States, Portugal, Puerto Rico